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Hypertension superimposed on type II diabetes in Goto Kaki- A dramatic increase in the incidence of end-stage renal
zaki rats induces progressive nephropathy. disease (ESRD) in patients with type II diabetes has
Background. Type II diabetes in the Goto Kakizaki (GK) been observed in recent years. Diabetic nephropathy,rats (derived from Wistar rats) is not associated with the devel-
mainly due to type II diabetes, is now the leading causeopment of obesity, hyperlipidemia, hypertension, or pro-
nounced renal functional changes. The aim of this study was of ESRD in the United States, Japan, and Europe [1–3].
to investigate the effect of superimposed hypertension on renal However, the pathogenesis of nephropathy associated
function and morphology under conditions of hyper- and nor- with type II diabetes is still not fully understood. Whilemoglycemia.
nearly 90% of all diabetics suffer from type II diabetes,Methods. The evolution of biochemical and morphologic
renal changes was examined in GK and Wistar rats treated only 20% to 50% of patients with type II diabetes de-
with deoxycorticosterone acetate (DOCA) salt over 24 weeks. velop nephropathy after 20 years of diabetes, depending
Results. Blood pressure was increased from 6 weeks on in upon the population studied [4]. Therefore, factors otherGK and Wistar rats with no difference in blood pressure levels
than hyperglycemia in isolation are obviously involvedbetween both groups (week 24, 183  14 mm Hg vs. 191 
13 mm Hg, P  NS, vs. 144  6 mm Hg in normal controls, in the development of diabetic renal disease.
P  0.01). A progressive increase in proteinuria was observed Various animal models have been used to gain more
in hypertensive GK rats from 12 weeks on (week 24, 168  insight into the pathogenesis of the nephropathy associ-62 mg/day vs. 41  30 mg/day in hypertensive Wistar rats,
ated with type II diabetes [5]. However, many of theseP  0.002). Histologic analysis at weeks 15 and 24 showed
progressive glomerulosclerosis in hypertensive GK and Wistar models exhibit other features of the metabolic syndrome
rats (week 24, 13  4% vs. 8  1%, P  NS) but not in in addition to diabetes, such as hyperlipidemia, obesity,
nonhypertensive GK controls. This was associated with evi- or hypertension. In some models, autoimmune phenom-dence of podocyte damage (de novo desmin expression) in
ena or urogenital structural abnormalities are also pres-hypertensive as compared to nonhypertensive GK rats (week
24, score 1.4 0.1 vs. 0.8 0.1, P 0.001) while no significant ent. This makes the pathogenetic relevance of each con-
increase was observed in hypertensive vs. nonhypertensive founding factor in the development of diabetic renal
Wistar rats. Tubulointerstitial damage was increased in hyper- disease in these models difficult to assess. In contrast, thetensive GK as compared to hypertensive Wistar rats (week 24,
Goto Kakizaki (GK) rat is a relatively unique strain inscore 1.5 0.6 vs. 0.6 0.3, P 0.01). By immunohistochemis-
try, this was associated with an up-regulation of tubulointersti- that it develops no obesity, hyperlipidemia, or hyperten-
tial type IV collagen as well as -smooth muscle actin (-SMA) sion and no progressive nephropathy. The GK rat was
expression, macrophage infiltration and cell proliferation in developed from a stock of Wistar rats by selective breed-hypertensive GK rats.
ing of those rats with the highest blood glucose levelsConclusion. Our data demonstrate that long-standing type
II diabetes alone is not sufficient to induce progressive ne- during an oral glucose tolerance test over many genera-
phropathy unless secondary injurious mechanisms such as hy- tions [6]. In the GK rat, moderate diabetes usually occurs
pertension are present. The hypertensive GK rat provides a between 3 and 4 weeks of age and is the result of severalnovel model to investigate the mechanisms involved in diabetic
pathomechanisms, including impaired ontogenetic de-nephropathy.
velopment of islet cells [7], abnormal insulin release fol-
lowing a glucose load [8], insulin resistance [9, 10], a basalKey words: GK rat, type II diabetes, hypertension, podocyte, diabetic
nephropathy. hyperinsulinemia [7], as well as an abnormal glucose
metabolism [8]. GK rats develop thickening of the glo-Received for publication March 21, 2002
merular and tubular basement membranes as well asand in revised form November 5, 2002
Accepted for publication January 17, 2003 glomerular hypertrophy [11]. They do, however, not de-
velop glomerulosclerosis or interstitial fibrosis. More- 2003 by the International Society of Nephrology
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over, prolonged hyperglycemia and hyperinsulinemia in and tubulointerstitial injury, cellular expression of the
cytoskeletal proteins -smooth muscle actin (-SMA)the GK rat is not associated with renal functional
changes, in particular no marked proteinuria or renal and desmin, cell proliferation (as assessed by immuno-
staining for BrdU), infiltrating monocytes/macrophages,function impairment [11].
The aim of the present study was to further test the expression of the extracellular matrix protein type IV
collagen, expression of the chemokine monocyte chemo-hypothesis that the development of progressive diabetic
renal disease requires additional factors other than hy- attractant protein-1 (MCP-1), as well as peritubular cap-
illary density.perglycemia. To investigate the effect of superimposed
hypertension on renal function and morphology under
Renal morphologyconditions of hyper- and normoglycemia deoxycorticos-
terone acetate (DOCA) salt hypertension, a model of Tissue for light microscopy and immunoperoxidase
staining was fixed in methyl Carnoy’s solution [13] andmineralcorticoid-mediated hypertension, was induced in
GK and Wistar rats. embedded in paraffin. Four micrometer sections were
stained with the periodic acid-Schiff (PAS) reagent and
counterstained with hematoxylin. The percentage of glo-
METHODS
meruli exhibiting focal glomerulosclerosis (FSGS) was
Experimental design determined. FSGS was evaluated by an observer who
was unaware of the origin of the slides and was evidencedAll animal experiments were approved by the local
review boards. Eleven-week old male GK rats, bred in by segmental increases in glomerular matrix, segmental
collapse and obliteration of capillary lumina, and accu-the animal facilities of the University of Wales College
of Medicine in Cardiff, as well as weight-matched male mulation of hyaline. Such changes were frequently asso-
ciated with synechial attachments to Bowman’s capsule.Wistar rats, obtained from Charles River, United King-
dom, were used in the experiments. The experimental Tubulointerstitial injury was defined as inflammatory cell
infiltrates, tubular dilation and/or atrophy, or interstitialanimals were randomly divided into three groups of each
GK and Wistar rats: (1) DOCA salt rats that were in- fibrosis. Injury was graded according to Shih, Hines, and
Neilson [14] on a scale of 0 to 4 (0 normal, 0.5 smalljected subcutaneously twice weekly with DOCA (Sigma,
Deisenhofen, Germany), 25 mg/kg body weight suspended focal areas of damage, 1  involvment of less than 10%
of the cortex, 2 involvment of 10 to 25% of the cortex,in corn oil (25 mg DOCA/mL corn oil), and received
1% NaCl added to tap water for drinking; (2) vehicle 3  involvment of 25 to 75% of the cortex, and 4 
extensive damage involving more than 75% of the cortex).salt rats that were injected subcutaneously twice weekly
with corn oil (vehicle), 1 mL/kg body weight, and re-
Immunoperoxidase stainingceived 1% NaCl added to tap water for drinking; and (3)
DOCA tap water rats that were injected subcutaneously Four micrometer sections of methyl Carnoy’s fixed bi-
opsy tissue were processed by an indirect immunoper-twice weekly with DOCA, 25 mg/kg body weight sus-
pended in corn oil (25 mg DOCA/mL corn oil), and oxidase technique as previously described [13]. Primary
antibodies included the following: (1) 1A4, a murinereceived tap water for drinking. Each group consisted
of six to seven animals. All rats were fed standard rat monoclonal antibody to an NH2-terminal synthetic deca-
peptide of -SMA (Dako, Glostrup, Denmark) [15], (2)chow. Renal biopsies for histologic evaluation were ob-
tained 15 weeks after start of injections by intravital D33, a murine monoclonal immunoglobulin G (IgG1)
antibody against human muscle desmin (Dako) [16], (3)biopsy [12] of the left kidney and postmortem 24 weeks
after start of injections. Twenty-four–hour urine collec- BU-1, a murine monoclonal antibody against BrdU [17]
containing nuclease in Tris-buffered saline (Amersham,tions were performed 1 week before the start of injec-
tions and on weeks 4, 8, 12, 16, 20, and 24 after start Braunschweig, Germany), (4) ED1, a murine mono-
clonal IgG antibody to a cytoplasmic antigen present inof injections to determine proteinuria and albuminuria.
Serum was obtained before and 24 weeks after start of monocytes, macrophages, and dendritic cells (Bioprod-
ucts for Science, Indianapolis, IN, USA) [18], (5) affinity-injections. Systolic blood pressures were determined by
tail plethysmography in conscious, restrained rats. The purified polyclonal goat antihuman/bovine type IV colla-
gen IgG preabsorbed with rat erythrocytes (Southernaverage of three pressure readings was obtained. Blood
pressures were measured before start of injections and Biotechnology, Birmingham, AL, USA), and (6) JG-12, a
murine monoclonal antibody to rat endothelial cells [19].every 2 weeks throughout the study. The thymidine ana-
log 5-bromo-2’-deoxyuridine (BrdU) (Sigma), 100 mg/kg For all biopsies, negative controls consisted of substi-
tution of the primary antibody with equivalent concen-body weight, was injected intraperitoneally 4 hours be-
fore sacrifice of the animals on week 24. After sacrifice, trations of an irrelevant murine monoclonal antibody
or normal goat IgG. All slides were evaluated by ankidneys were quickly removed and the right kidney was
weighed. Renal tissue was studied to assess glomerular observer who was unaware of the origin of the slides.
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To obtain mean numbers of proliferating cells or infil-
trating monocytes/macrophages in glomeruli, an average
of 50 consecutive cross-sections of glomeruli were evalu-
ated and mean values per kidney were calculated. To
obtain counts of proliferating cells or infiltrating mono-
cytes/macrophages in the renal cortex, an average of 30
grid fields, measuring 0.36 mm2 each, were analyzed, and
again mean counts per kidney were obtained.
For the evaluation of the immunoperoxidase stains
for -SMA, desmin, and type IV collagen each glomeru- Fig. 1. Systolic blood pressure in Goto Kakizaki (GK) (A ) and Wistar
rats (B ) 1 week before and every 2 weeks after start of treatmentlar area or tubulointerstitial grid field was graded semi-
with deoxycorticosterone acetate (DOCA) salt (), vehicle salt (),quantitatively, and the mean score per biopsy was calcu-
or DOCA tap water (). *P  0.05 vs. control.
lated. Each score reflects mainly the changes in the extent
rather than intensitiy of staining and depended on the
percentage of the glomerular tuft area or grid field show-
ing positive staining: 0  absent staining or less than 5% Miscellaneous measurements
of the area stained, I  5% to 25%, II  25% to 50%, Urinary protein was measured using the Bio-Rad Pro-
III  50% to 75%, and IV  75%. We and others tein Assay (Bio-Rad Laboratories GmbH, Mu¨nchen, Ger-
have described that this semiquantitative scoring system many) and bovine serum albumin (Sigma Chemical Co.,
is not only reproducible among different observers, but St. Louis, MO, USA) as a standard. Albuminuria was
that the data also are highly correlated with those ob- determined by rocket immunoelectrophoresis at weeks
tained by computerized morphometry [20, 21]. To assess 1, 12, and 24 using rat albumin as a standard (Sigma-
peritubular capillary density sections were stained for Aldrich Co., Ltd., Poole, UK) [24]. Serum glucose and
JG-12 and the numbers of squares in 10  10 grids that creatinine were measured using an autoanalyzer (Syn-
chron CX7 Beckman analyzer, Beckman Instruments,did contain JG-12–positive peritubular capillary staining
High Wycombe, UK). Cholesterol and triglyceride levelswere determined in at least 20 nonoverlapping sequential
were determined by clinical routine methods. Insulinfields, at 400 magnification, and the mean percentage
levels 24 weeks after start of injections were determinedof grids containing JG-12–positive staining was calcu-
by enzyme-linked immunosorbent assay (ELISA). ELISAlated per biopsy (modified after Kang et al [22]).
analysis was performed using a rat insulin ELISA fromFor the immunohistochemistry of MCP-1, acetone-
Mercodia (Uppsala, Sweden) according to the instruc-fixed 5 m sections of snap-frozen kidney tissue were in-
tions of the manufacturer.cubated with a goat antirat MCP-1 antibody (Santa Cruz
Biotechnology, Inc., Heidelberg, Germany) [23]. MCP-1 Statistical analysis
protein was then visualized by an indirect immunoperox-
Values are expressed as mean  SD. Values wereidase procedure, using diaminobenzidine as a chromo-
compared using the Kruskal-Wallis and Mann-Whitneygen. Negative controls consisted of substitution of the
U tests. Statistical significance was defined as P  0.05.primary antibody with equivalent concentrations of nor-
mal goat IgG, in which case no staining was noted. Semi-
quantitative evaluation of MCP-1 staining was performed RESULTS
as described above. Effects of DOCA salt on blood pressure and
renal function in GK and Wistar rats
Electron microscopy
DOCA salt treatment induced hypertension in GK
Renal tissue (1 mm3 blocks) were fixed for at least and Wistar rats from 6 weeks on as compared to vehicle
24 hours in 1.25% glutaraldehyde dissolved in a buffer salt or DOCA tap water–treated controls. There was no
containing 0.04 mol/L cacodylic acid (pH 7.2). Tissue significant difference in blood pressure levels between
was then processed for transmission electron microscopy DOCA salt–treated GK and Wistar rats at any time
by standard procedures. For evaluation of the electron point investigated (week 24, 183  14 mm Hg vs. 191 
microscopy sections the glomerular profiles of each ani- 13 mm Hg, P  NS, vs. 144  6 mm Hg in controls, P 
mal were analyzed and the number of glomeruli per 0.01) (Fig. 1).
biopsy exhibiting abnormalities, such as podocytic foot DOCA salt hypertension led to increased kidney
process effacement, microvilli formation, or podocytic weights in both GK and Wistar rats at week 24 as com-
cytoplasmic inclusions, were counted. For each finding pared to nonhypertensive controls. Moreover, relative
kidney weights in hypertensive GK rats were slightlymean values per biopsy were obtained.
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Table 1. Body weight, kidney weight, and renal functional changes in Goto Kakizaki (GK) and Wistar rats
Week after Body Kidney Serum
start of weight weight Kidney weight creatinine Proteinuria Albuminuria
Rat strain Treatment treatment g g % of body weight lmol/L mg/24 hours mg/24 hours
GK rats DOCA salt 1 27832 ND ND 494 8.36.8 0.310.17
12 37536 ND ND ND 35.618.3a 15.5711.30a
24 41039 1.830.11a 0.450.03a,b 558 168.362.1a,b 112.0236.90a,b
Vehicle salt 1 27624 ND ND 474 8.22.8 0.370.09
12 37523 ND ND ND 19.34.5 1.812.02
24 41223 1.270.08 0.310.01 5316 23.65.1 2.772.72
DOCA tap water 1 26917 ND ND 485 16.414.5 0.690.47
12 36117 ND ND ND 14.810.9 1.250.98
24 39211 1.580.27 0.400.07 526 20.814.8 9.718.21
Wistar rats DOCA salt 1 26011 ND ND 5914 7.63.3 0.280.12
12 40416c ND ND ND 25.714.6c 6.0710.39c
24 43119 1.740.15c 0.400.03c 507 41.129.9c 25.6025.18c
Vehicle salt 1 2559 ND ND 536 5.42.6 0.220.14
12 38130 ND ND ND 14.42.2 0.420.16
24 43936 1.160.09 0.270.04 5211 10.54.1 0.510.25
DOCA tap water 1 2597 ND ND 536 7.32.2 0.160.06
12 36326 ND ND ND 10.42.0 0.240.06
24 39926 1.260.11 0.320.01 456 6.91.7 0.480.11
Data are mean  SD; N  six to seven each; ND is not determined.
a P  0.05 DOCA salt–treated GK rats versus vehicle salt and DOCA tap water–treated GK rats
b P  0.05 DOCA salt–treated GK rats versus DOCA salt–treated Wistar rats
c P  0.05 DOCA salt–treated Wistar rats versus vehicle salt and DOCA tap water–treated Wistar rats
There was no significant difference in glucose levels be-
tween DOCA salt, vehicle salt, or DOCA tap water–
treated GK rats at all time points investigated (Table 2).
Administration of DOCA resulted in reduced insulin
levels in both DOCA salt as well as DOCA tap water–
treated GK rats as compared to vehicle salt–treated GK
controls at week 24 (Table 2). Moreover DOCA salt
treatment led to mild increases in cholesterol as well as
triglyceride levels in GK but not in Wistar rats (Table 2).
Glomerular changes in GK and Wistar rats with
Fig. 2. Proteinuria in Goto Kakizaki (GK) (A) and Wistar rats (B) DOCA salt hypertension
1 week before and every 4 weeks after start of treatment with deoxycor-
ticosterone acetate (DOCA) salt (), vehicle salt (), or DOCA tap By light microscopy, FSGS developed in 13% of glo-
water (). *P  0.05 vs. controls; **P  0.05 vs. DOCA salt–treated meruli in GK and 8% of glomeruli in Wistar rats with
Wistar rats and controls.
DOCA salt hypertension at week 24 (Fig. 3A). The dif-
ference did, however, not reach statistical significance.
increased as compared to hypertensive Wistar rats (Ta- The glomerular lesions in both hypertensive GK and
ble 1). Renal function, as assessed by serum creatinine, Wistar rats were focally distributed and were of the “clas-
remained normal during the treatment period until week sic-type” FSGS. Nodular Kimmelstiel-Wilson lesions
24 (Table 1). Both hypertensive GK and Wistar rats were not observed in hypertensive GK rats. FSGS was ac-
developed proteinuria from 12 weeks on as compared companied by a slight increase in glomerular matrix ac-
to nonhypertensive controls. However, DOCA salt hy- cumulation, as assessed by immunostaining for type IV
pertension induced progressive proteinuria in GK but collagen, in both hypertensive GK and Wistar rats as
not in Wistar rats (week 24, 168  62 mg/day vs. 41 
compared to nonhypertensive controls (Fig. 3B). No dif-30 mg/day, P  0.002) (Fig. 2). Rocket immunoelectro-
ference in glomerular type IV collagen expression wasphoresis demonstrated a 4.4-fold increase in albuminuria
observed between hypertensive GK and Wistar rats.in hypertensive GK compared to hypertensive Wistar
Mild glomerular de novo expression of -SMA, a markerrats after 24 weeks (Table 1).
of activated mesangial cells [25], was noted in hyperten-
Effects of DOCA salt on metabolic characteristics in sive GK and Wistar rats as compared to nonhypertensive
GK and Wistar rats controls. Again, there was no difference in glomerular
-SMA expression between hypertensive GK and WistarDOCA salt hypertension had no apparent influence
on the moderate hyperglycemia observed in GK rats. rats (Fig. 3C).
Janssen et al: Hypertension in Goto Kakizaki rats2166
Table 2. Metabolic characteristics of Goto Kakizaki (GK) and Wistar rats
Week after
start of Glucose Cholesterol Triglycerides Insulin
Rat strain Treatment treatment mmol/L mmol/L mmol/L lg/L
GK rats DOCA salt 1 11.81.1b 2.20.5 0.920.32 ND
24 11.62.0b 2.90.5a,b 1.270.21b 1.20.3b
Vehicle salt 1 13.21.0 2.00.5 0.870.24 ND
24 15.34.4 2.10.5 0.900.30 2.40.7
DOCA tap water 1 14.13.5 1.70.6 1.080.53 ND
24 14.34.1 1.70.6 0.880.29 1.40.4
Wistar rats DOCA salt 1 8.60.6 1.90.1 0.520.28 ND
24 8.40.8 1.40.1 0.870.13 0.50.2
Vehicle salt 1 8.90.7 1.80.2 0.900.31 ND
24 9.11.4 1.60.2 1.830.64 ND
DOCA tap water 1 8.90.9 1.80.1 0.680.31 ND
24 8.71.2 1.20.1 0.800.14 ND
Data are mean  SD; N  six to seven each; ND is not determined.
a P  0.05 DOCA salt–treated GK rats versus vehicle salt and DOCA tap water–treated GK rats
b P  0.05 DOCA salt–treated GK rats versus DOCA salt–treated Wistar rats
Fig. 4. Renal desmin immunostaining. (A) A nonhypertensive Goto
Kakizaki (GK) control rat 24 weeks after start of treatment with vehicle
salt. Desmin expression is confined to the mesangium. (B) A hyperten-
sive Wistar rat 24 weeks after start of treatment with deoxycorticoster-
one acetate (DOCA) salt. Desmin expression mostly exhibits a normal
pattern in that it is confined to the mesangium. However, focal up-
regulation is present in two podocytes at the edge of the glomerular tuft
(arrows). (C ) A hypertensive GK rat 24 weeks after start of treatment
with DOCA salt. Glomerular desmin expression is markedly up-regu-
lated predominantely at the glomerular edge.
DOCA salt hypertension resulted in an apparent de novo
expression of desmin in podocytes that was more pro-
nounced in hypertensive GK than in hypertensive Wistar
rats (Fig. 4). This aggravation of podocyte damage led
to a significant increase in the glomerular desmin staining
score in hypertensive as compared to nonhypertensive
GK rats at week 24, while no significant increase was ob-
served in hypertensive versus nonhypertensive Wistar
Fig. 3. Glomerular histologic findings in Goto Kakizaki (GK) and Wistar rats (Fig. 3D).rats 15 and 24 weeks after start of treatment with DOCA salt (), vehicle-
salt ( ), or DOCA-tap water (). Quantitative assessment of glomeru- Glomerular monocyte/macrophage infiltration (Fig. 3E),
losclerosis (%) (A). Immunostaining scores for type IV collagen (B), as well as glomerular cell proliferation, as assessed by
-smooth muscle actin (-SMA) (C), and desmin (D). Monocyte/macro-
nuclear BrdU incorporation (Fig. 3F), did not differ be-phage influx: counts of ED1-positive monocytes/macrophages (E ). Cell
proliferation: counts of BrdU-positive cells (F ). ND  not determined. tween hypertensive GK and Wistar rats as well as non-
hypertensive controls. Only a very low-grade glomerular
MCP-1 expression was observed in isolated glomeruli in
both hypertensive GK and Wistar rats (data not shown).The normal glomerular expression of desmin in most rat
By electron microscopy, evidence of podocyte activa-strains is confined to mesangial cells, and podocytes only
express it following various types of injury [25, 26]. tion and damage was noted at week 24 in hypertensive
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Fig. 5. Electron microscopy findings. (A) Hypertensive Goto Kakizaki
(GK) rat 24 weeks after start of treatment with deoxycorticosterone
acetate (DOCA) salt. This shows podocytes with foot process efface-
ment (arrowheads) as well as dense bodies (arrows). (B) Hypertensive
GK rat 24 weeks after start of treatment with DOCA salt. Podocytes
with microvilli formation (arrowheads) and lamella bodies (arrows).
GK (Fig. 5) and Wistar rats. Focal areas of foot process
effacement were observed in 23% of glomeruli in GK
and 10% of glomeruli in Wistar rats with DOCA salt hy-
pertension. The difference did, however, not reach statis-
tical significance. Cytoplasmic inclusions, such as dense
bodies and lamella bodies, both markers of podocyte
damage, did not differ significantly between hypertensive
GK and Wistar rats (24  11% vs. 10  6%, P  NS).
Podocytic microvilli formation, another marker of podo-
Fig. 6. Tubulointerstitial histologic findings in Goto Kakizaki (GK) andcyte damage, was increased in hypertensive GK as com-
Wistar rats 15 and 24 weeks after start of treatment with deoxycortico-pared to hypertensive Wistar rats (36  9% vs. 11 
sterone (DOCA) salt (), vehicle salt ( ), or DOCA tap water ().
5%, P  0.05). In contrast, nonhypertensive GK rats Quantitative assessment of tubulointerstitial damage (A). Immunostain-
ing scores for type IV collagen (B) and -smooth muscle actin (-SMA)showed a normal podocyte morphology at week 24.
(C ). Monocyte/macrophage influx: counts of ED1-positive monocytes/
macrophages (D). Cell proliferation: counts of BrdU-positive cells (E ).Tubulointerstitial changes in GK and Wistar rats with
Immunostaining score for monocyte chemoattractant protein-1 (MCP-1)
DOCA salt hypertension (F ). ND  not determined.
By light microscopy, DOCA salt hypertension led to
tubulointerstitial damage in both GK and Wistar rats at
week 24 as compared to nonhypertensive controls. How-
pared to nonhypertensive GK rats at week 24 while noever, progressive proteinuria in hypertensive GK rats
significant increase was observed in hypertensive versuswas associated with significantly increased tubulointer-
nonhypertensive Wistar rats (Fig. 6D). Moreover, hyper-stitial damage as compared to hypertensive Wistar rats
tensive GK rats showed increased tubulointerstitial cell(Fig. 6A). This was accompanied by an increased tubulo-
proliferation, as assessed by nuclear BrdU incorporation,interstitial matrix accumulation, as assessed by immuno-
compared to nonhypertensive GK rats while no increasestaining for type IV collagen, in hypertensive GK as com-
was observed in hypertensive versus nonhypertensivepared to hypertensive Wistar rats (Fig. 6B).
Wistar rats (Fig. 6E). This increase was due to a signifi-In diseased kidney, the tubulointerstitial de novo ex-
cant increase in tubular as well as nontubular cell BrdUpression of -SMA has been demonstrated to specifically
incorporation in hypertensive GK rats (tubular BrdU–label interstitial (myo-) fibroblasts [27]. Increased tubu-
positive cells per 0.36 mm2, 4.92  2.18 vs. 2.08  0.54lointerstitial de novo expression of -SMA was noted at
in nonhypertensive GK controls at week 24, P  0.01;week 24 in hypertensive GK as compared to hyperten-
nontubular BrdU–positive cells per 0.36 mm2, 4.08 1.9sive Wistar rats (Fig. 6C). In the cortical tubulointersti-
vs. 1.62 0.5 in nonhypertensive GK controls at week 24,tium of both hypertensive GK and Wistar rats only very
P  0.01).small foci of desmin up-regulation were observed (data
Moreover tubulointerstitial damage in hypertensivenot shown).
GK rats was associated with an up-regulation of tubulo-An increase in tubulointerstitial monocyte/macro-
phage infiltration was observed in hypertensive as com- interstitial MCP-1 expression as compared to hyperten-
Janssen et al: Hypertension in Goto Kakizaki rats2168
sive Wistar rats as well as nonhypertensive controls at accordance with previous reports [32, 33] and may relate
to direct or indirect effects of DOCA on the assimilation,week 24 (Fig. 6F). Focal areas of tubulointerstitial MCP-1
expression were also observed in hypertensive as com- production, or utilization of glucose, leading to an im-
provement in insulin sensitivity and subsequently a de-pared to nonhypertensive Wistar rats. The difference
did, however, not reach statistical significance. crease in insulin secretion [34]. Finally, DOCA salt
hypertensive GK rats exhibited mild increases in cho-To assess whether increased proteinuria and tubulo-
interstitial damage in hypertensive GK rats was associ- lesterol as well as triglyceride levels. Since DOCA tap
water treatment in GK rats as well as DOCA salt andated with changes in the tubulointerstitial/peritubular
microvasculature, capillary densities (i.e., percentage of DOCA tap water treatment in Wistar rats did not result
in similar changes, it appears likely that hyperlipidemiaarea with capillary staining) were determined. There was,
however, no difference in peritubular capillary density was the consequence of the markedly increased and pro-
gressive proteinuria in DOCA salt hypertensive GK rats.between hypertensive GK and hypertensive Wistar rats
(week 24, 81.4  4.4% vs. 84.4  3.2%, P  NS). More- The main finding of the present study was that DOCA
salt hypertension induced progressive and marked pro-over, capillary densities did not differ between hyperten-
sive and non-hypertensive GK as well as hypertensive teinuria in GK as compared to Wistar rats. In this con-
text, it is notable that hypertensive GK rats, but notand nonhypertensive Wistar rats (data not shown).
hypertensive Wistar rats, exhibited a significant increase
of glomerular de novo expression of desmin as well as
DISCUSSION
electron microscopic changes in podocytes. These elec-
In the present study, we used the GK rat to assess the tron microscopic observations as well as the desmin over-
renal consequences of hypertension superimposed on expression, which serves as a nonspecific marker of podo-
type II diabetes. We recently described the renal func- cyte damage [26, 35, 36], support the widely held belief
tional and structural changes associated with prolonged that podocyte injury and proteinuria are central events
hyperglycemia in GK rats between 6 and 52 weeks of in the progression of renal damage [37]. Indeed, it has
age [11]. The development of type II diabetes in the GK recently been shown that podocyte loss contributes to
rat was associated with glomerular hypertrophy, as well the progression of diabetic nephropathy in human type
as thickening of the glomerular and tubular basement II diabetes [38]. Alternatively, proteinuria might have
membranes but neither glomerulosclerosis or interstitial been triggered by changes in the glomerular basement
fibrosis. Prolonged hyperglycemia and hyperinsulinemia membrane (GBM) thickness [39], which are also ob-
in the GK rat also were not associated with renal func- served in GK rats [11, 40] and develop at 8 to 12 weeks of
tional changes, such as overt proteinuria or renal func- age in these animals [40], as well as changes in the compo-
tion impairment. These findings are remarkably similar sition of the GBM (i.e., a reduction in the anionic charge
to the early preclinical phase of human diabetic nephrop- of the GBM due to undersulfated glycosaminoglycan side
athy [28]. The GK rat, therefore, seems to be an ideal chains of heparan sulfate proteoglycans, already present
model to examine the effects of secondary injurious fac- at early stages of diabetic nephropathy) [41]. In the pres-
tors on renal function and morphology in type II diabe- ence of hypertension an increased leakage of the GBM
tes. One of the most important of such factors is hyper- for macromolecules may, therefore, have resulted in more
tension, acting as a risk factor for nephropathy and a pronounced podocyte damage as well as damage pro-
contributor to progression in human type II diabetes gression in diabetic GK as compared to nondiabetic Wis-
[29, 30]. tar rats. The absorption of a large number of macromole-
In the present study administration of DOCA salt, cules by podocytes can result in an overload in lysosomal
a model of mineralcorticoid-induced, volume-expanded degradation, spillage of lysosomal enzymes into the cyto-
experimental hypertension, resulted in an increase in plasm, ultimately leading to podocyte damage and cell
blood pressure in diabetic GK as well as nondiabetic death. Such a mechanism has recently been suggested
Wistar rats from 6 weeks on. A potential confounder of by Gassler et al [42] in the development of glomerulo-
the present study is the fact that GK rats fed a high sclerosis and progressive renal damage in fa/fa Zucker
sodium diet containing 6% NaCl have been reported to rats, a model of type II B diabetes. Interestingly, some
develop a moderate salt-sensitive hypertension [31]. An of the electron microscopic changes in podocytes in the
increased salt-sensitivity of GK rats, however, failed to fa/fa Zucker rat [42] were remarkably similar to the ones
affect the present study since blood pressure levels did observed in the present study. An increased podocyte
not differ significantly between DOCA salt hypertensive damage in hypertensive GK rats may then, in turn, have
GK and DOCA salt hypertensive Wistar rats. Second, we contributed to a further impairment of the glomerular
noted that DOCA treatment led to significantly reduced filtration barrier and an aggravation of proteinuria. The
insulin levels as compared to vehicle salt-treated animals observation that increased proteinuria in hypertensive
GK rats preceeded the development of more pronouncedbut did not affect glucose levels. This observation is in
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podocyte damage may support this hypothesis. In con- possibly through the recruitment and activation of mono-
cytes/macrophages. Interestingly, the reduction of pro-trast to the potential role of podocytes, we failed to
obtain evidence for a specific role of mesangial cell dam- teinuria by converting enzyme inhibition prevented renal
interstitial expansion in type II diabetic patients [51].age in the context of combined diabetic and hypertensive
glomerular injury. Whereas both low-grade glomerular
-SMA overexpression, a sensitive marker of mesangial
CONCLUSION
cell activation [25], and glomerular accumulation of type
DOCA salt hypertension in diabetic GK as comparedIV collagen were noted in hypertensive GK rats, similar
to nondiabetic Wistar rats resulted in increased and pro-changes occurred in hypertensive Wistar rats as well.
gressive proteinuria, a mild increase in cholesterol levels,The second major finding of the present study was
more pronounced podocyte damage, and increased tubu-that, in contrast to glomerular changes, which showed
lointerstitial injury. Our observations in the GK rat dem-few differences between hypertensive GK and Wistar
onstrate that the development of progressive diabeticrats, tubulointerstitial injury was much more pronounced
nephropathy requires second injurious factors such asin hypertensive GK as compared to Wistar rats. This was
hypertension in addition to hyperglycemia and hyper-characterized by tubulointerstitial matrix accumulation,
insulinemia. The hypertensive GK rat provides a novelmyofibroblast activation, MCP-1 expression, as well as
model to study the mechanisms involved in diabetic ne-macrophage infiltration and cell proliferation. A possible
phropathy.explanation for this observation might be increased dam-
age to the tubulointerstitial vasculature in hypertensive
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